The second objective of this study is to examine the effect of EPO and the non-hematopoietic peptide pHBSP in a murine model of HUS by measuring surrogate parameters of kidney injury and dysfunction, intrarenal barrier integrity, microangiopathy, oxidative and nitrosative stress and metabolome. Here, EPO is linked to hemolytic-uremic syndrome.